Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion type Assertion NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_head.
- NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion description "[The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_provenance.
- NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion evidence source_evidence_literature NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_provenance.
- NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion SIO_000772 21538969 NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_provenance.
- NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion wasDerivedFrom befree-2016 NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_provenance.
- NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_assertion wasGeneratedBy ECO_0000203 NP891416.RA4mmPA0-jXlA_Tn0xuzpdMibbEFtEp_MQNlzGvGmRgbs130_provenance.